Posted: Sep 19, 2016
The NCI-UMD Partnership for Integrative Cancer Research kicked off the Fall 2016 semester with a meet and greet Friday, Sept. 16. The partnership “aims to bring together the expertise and resources in the mathematical sciences, physical sciences, and engineering at the University of Maryland College Park, with basic, clinical, and translational research expertise of the National Cancer Institute/Center for Cancer Research to solve the most pressing problems in cancer research.” CCR Deputy Director Carole Parent is one of the co-directors of the partnership.
Dr. Jonathan Hernandez appointed as tenure track investigator
Posted: Sep 6, 2016
CCR is pleased to announce the appointment of Jonathan Hernandez as a Tenure Track Investigator in the Thoracic and Gastrointestinal Oncology Branch (TGIB). Dr. Hernandez will be developing a clinical program focused on innovative surgical management of pancreatic and hepatobiliary malignancies, including the development of novel approaches to the diagnosis and treatment of these neoplasms through his laboratory research. His service responsibilities will include surgical management of patients with GI malignancies on TGIB protocols, as well as consults from other NIH services.
Posted: Aug 25, 2016
Ping Zhang, Ph.D. has been appointed as a Stadtman Tenure Track Investigator in the Structural Biophysics Laboratory (SBL). Dr. Zhang’s expertise is in the fields of X-ray crystallography and cryoEM for the study of multicomponent complexes relevant to cancer and human disease. Her program is expected to be synergistic with the existing program with the SBL and to expand the expertise into the rapidly developing area of cryoEM investigation of proteins and protein-complexes.
Posted: Aug 23, 2016
Ramaprasad Srinivasan, M.D., Ph.D., has been appointed as a Tenure Track Investigator in the Urologic Oncology Branch. Dr. Srinivasan is a recognized expert in genitourinary oncology, notably in targeted therapeutic approaches for patients with advanced forms of renal cell carcinoma. His research focuses on developing and conducting clinical trials using molecular treatment approaches targeting kidney cancer pathways and targeted therapeutic agents in patients with localized and advanced forms of kidney cancer. He is currently investigating a variety of newer targeted agents in clear cell and papillary kidney cancer, as well as hereditary kidney cancer syndromes, such as von Hippel-Lindau, hereditary leiomyomatosis, and renal cell cancer and hereditary papillary renal cell cancer.
Posted: Aug 17, 2016
Posted: Aug 17, 2016
Kandice Tanner was selected as one of the 2016 Cellular and Molecular Bioengineering (CMBE) Young Innovators. She will present her work on the mechanical properties of the tumor stromal microenvironment at the 2016 Annual Biomedical Engineering Society Meeting in Minneapolis, Minnesota on October 5–8, 2016.
Posted: Aug 9, 2016
Ramiro Iglesias-Bartolome has joined CCR as a Stadtman Tenure Track Investigator in the Laboratory of Cellular and Molecular Biology (LCMB). Dr. Iglesias-Bartolome’s research focuses on identifying GPCRs that are expressed in epithelial stem cells and that regulate their proliferation and differentiation; identifying and studying heterotrimeric G proteins coupled to the GPCRs; and identifying and characterizing cytoplasmic and nuclear events downstream of the GPCRs and G proteins.
Posted: Jul 25, 2016
Dr. Jing Huang, Laboratory of Cancer Biology and Genetics, has received NIH Tenure. Dr. Huang’s research explores repression and activation of gene expression by the p53 tumor suppressor protein and the role this regulation has on embryonic and mesenchymal stem cell biology. Using genome wide and epigenetic approaches both in vitro and in mouse models, Jing’s work is contributing to our understanding of p53-related therapy for stem cell diseases and cancer.
Posted: Jul 25, 2016
Dr. Christine Alewine, Laboratory of Molecular Biology, has been appointed as a Lasker Scholar Tenure-Track Investigator. Dr. Alewine’s research focuses on using novel therapies to target pancreatic cancer, with an interest in immunotoxin therapeutics and how these can be used to improve outcomes for patients.
Posted: Jul 12, 2016
CCR is pleased to announce the appointment of Jung-Min Lee, M.D. as a Lasker Scholar Investigator in the Women’s Malignancies Branch. Dr. Lee’s research focuses on investigating the biology of breast and ovarian cancers, developing novel therapeutic strategies, and evaluating these therapeutic approaches in clinical trials.